Analysis of Subject Related Costs in Medical Research
10.12026/j.issn.1001-8565.2022.04.11
- VernacularTitle:医学研究中与受试者相关的费用问题分析
- Author:
Jiajing ZHANG
1
;
Keying LI
1
;
Zhendong WEI
1
;
Jinhai YAN
2
Author Information
1. School of Health Management, Southern Medical University, Guangzhou 510515, China
2. General Education Department, Southern Medical University, Guangzhou 510515, China
- Publication Type:Journal Article
- Keywords:
Medical Research;
Cost of Subjects;
Medical Research Damage Compensation Fund;
Research Damage Insurance System
- From:
Chinese Medical Ethics
2022;35(4):415-420
- CountryChina
- Language:Chinese
-
Abstract:
The development of medical research is completed by the cooperation of sponsors, investigators, subjects, and ethics committees. Clinically, it mainly includes clinical trials of medical devices, clinical medicine and new technology research. This paper analyzed the game and the relationship between rights, responsibilities and interests of relevant parties in medical research, combined with the relevant costs and sharing principles involved in medical research, and found that the use of the word "free" in the informed consent is easy to cause misunderstanding and the lack of relevant compensation costs in the informed consent, while the compensation and insurance costs had some problems, such as the imperfect subject compensation mechanism and the insufficient insurance purchase by the sponsor, which can not protect the basic rights and interests of the subjects. Therefore, in order to standardize the cost management of clinical medical research, it is necessary to standardize the process and content of informed consent, strengthen the supervision of medical research process, establish medical research damage compensation fund and research damage insurance system, so as to better protect the rights and interests of subjects.
